Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Leveraging histone glycation for cancer diagnostics and therapeutics

Trends in cancer(2023)10.1016/j.trecan.2023.01.005Source: DataRank Database

Leveraging histone glycation for cancer diagnostics and therapeutics is a research paper published in Trends in cancer (2023). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.39)OA: greenTopics (32)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Yang Xiao ORCID,Yael David ORCID,Anna Knörlein ORCID

Live enrichment

PubMed:36804508 PMC:PMC10121827 OpenAlex:https://openalex.org/W4321378559

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Grant: 214384

NIH

Grant: R35 GM138386

NCI NIH HHS

Grant: P50 CA192937

NCI NIH HHS

Grant: P30 CA008748

Commonwealth Foundation for Cancer Research Foundation

Pershing Square Sohn Cancer Research Alliance

Parker Institute for Cancer Immunotherapy

FWCI

1.39

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10121827/pdf/nihms-1868689.pdf

publisherhttps://api.elsevier.com/content/article/PII:S2405803323000079?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2405803323000079?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10121827

Fields of Study

Epigenetics and DNA MethylationAdvanced Glycation End Products researchPeroxisome Proliferator-Activated ReceptorsHumansHistonesMaillard ReactionEpigenesis, GeneticNeoplasms

MeSH Terms

HistonesHumansNeoplasmsMaillard ReactionEpigenesis, Genetic

Keywords

GlycationEpigeneticsHistoneWarburg effectReprogrammingChemistryChromatinCancer cellCancerCell biologyBiochemistryGlycolysisBiologyMetabolismGeneticsCellDNAPost-translational modificationsCancer Therapeutics

Sustainable Development Goals

SDG 0: Good health and well-being